FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Sterin Steven
2. Issuer Name and Ticker or Trading Symbol

Celanese CORP [ CE ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP and CFO
(Last)          (First)          (Middle)

C/O CELANESE CORPORATION, 1601 W. LBJ FREEWAY
3. Date of Earliest Transaction (MM/DD/YYYY)

1/2/2008
(Street)

DALLAS, TX 75234
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Series A Common Stock   1/2/2008     M    10000   A $21.02   11500   D    
Series A Common Stock   1/2/2008     M    15000   A $20.37   26500   D    
Series A Common Stock   1/2/2008     S    3200   D $42.87   23300   D    
Series A Common Stock   1/2/2008     S    100   D $43.06   23200   D    
Series A Common Stock   1/2/2008     S    900   D $43.07   22300   D    
Series A Common Stock   1/2/2008     S    300   D $43.08   22000   D    
Series A Common Stock   1/2/2008     S    300   D $43.09   21700   D    
Series A Common Stock   1/2/2008     S    300   D $43.10   21400   D    
Series A Common Stock   1/2/2008     S    400   D $43.11   21000   D    
Series A Common Stock   1/2/2008     S    1200   D $43.12   19800   D    
Series A Common Stock   1/2/2008     S    1200   D $43.13   18600   D    
Series A Common Stock   1/2/2008     S    100   D $43.14   18500   D    
Series A Common Stock   1/2/2008     S    2600   D $43.15   15900   D    
Series A Common Stock   1/2/2008     S    1600   D $43.17   14300   D    
Series A Common Stock   1/2/2008     S    300   D $43.18   14000   D    
Series A Common Stock   1/2/2008     S    700   D $43.20   13300   D    
Series A Common Stock   1/2/2008     S    1900   D $43.21   11400   D    
Series A Common Stock   1/2/2008     S    1300   D $43.22   10100   D    
Series A Common Stock   1/2/2008     S    800   D $43.24   9300   D    
Series A Common Stock   1/2/2008     S    1200   D $43.25   8100   D    
Series A Common Stock   1/2/2008     S    1200   D $43.26   6900   D    
Series A Common Stock   1/2/2008     S    200   D $43.27   6700   D    
Series A Common Stock   1/2/2008     S    1500   D $43.29   5200   D    
Series A Common Stock   1/2/2008     S    300   D $43.30   4900   D    
Series A Common Stock   1/2/2008     S    300   D $43.31   4600   D    
Series A Common Stock   1/2/2008     S    500   D $43.32   4100   D    
Series A Common Stock   1/2/2008     S    300   D $43.33   3800   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)   $21.02   1/2/2008           10000      (1) 5/16/2016   Series A Common Stock   10000   $0   30000   D    
Non-Qualified Stock Option (right to buy)   $20.37   1/2/2008           15000      (1) 6/30/2016   Series A Common Stock   15000   $0   45000   D    

Explanation of Responses:
(1)  Granted pursuant to the Company's 2004 Stock Incentive Plan. The option shares vested with respect to 25% of the grant on January 1, 2008 and will vest, subject to Mr. Sterin's continued employment with Celanese, with respect to 25% of the grant on January 1, 2009, January 1, 2010 and January 1, 2011.

Remarks:
The sale transactions reported on this Form 4 were effected pursuant to a Rule 10b 5-1 trading plan adopted by the Reporting Person. This is Part One of a Form 4 filed by the reporting person. The Form 4 was filed in two parts due to the restrictions in the electronic filing process.





Exhibit List: Exhibit 24.1 Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Sterin Steven
C/O CELANESE CORPORATION
1601 W. LBJ FREEWAY
DALLAS, TX 75234


SVP and CFO

Signatures
/s/ Robert L. Villasenor, Attorney-in-Fact for Steven Sterin 1/4/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
LIMITED POWER OF ATTORNEY FOR

SECTION 16 REPORTING OBLIGATIONS

Know all by these presents that the undersigned hereby makes, constitutes and
appoints Robert L. Villasenor, Alexander M Ludlow or Curtis S. Shaw as the
undersigned's true and lawful attorney-in-fact, with full power and authority
as hereinafter described on behalf of and in the name, place and stead of the
undersigned to:

(1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5
(including any amendments thereto) with respect to the securities of Celanese
Corporation, a Delaware corporation (the "Company"), with the United States
Securities and Exchange Commission and any national securities exchanges, as
considered necessary or advisable under Section 16(a) of the Securities
Exchange Act of 1934 and the rules and regulations promulgated thereunder, as
amended from time to time (the "Exchange Act");

(2) seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information on transactions in Celanese's securities
from any third party, including brokers, employee benefit plan administrators
and trustees, and the undersigned hereby authorizes any such person to
release any such information to the undersigned and approves and ratifies any
such release of information; and

(3) perform any and all other acts which in the discretion of such attorney-
in-fact are necessary or desirable for and on behalf of the undersigned in
connection with the foregoing.

The undersigned acknowledges that:

(1) this Power of Attorney authorizes, but does not require, such attorney-
in-fact to act in their discretion on information provided to such attorney-
in-fact without independent verification of such information;

(2) any documents prepared and/or executed by such attorney-in-fact on behalf
of the undersigned pursuant to this Power of Attorney will be in such form
and will contain such information and disclosure as such attorney-in-fact, in
his or her discretion, deems necessary or desirable;

(3) neither Celanese nor such attorneys-in-fact assumes (i) any liability for
the undersigned's responsibility to comply with the requirement of the
Exchange Act, (ii) any liability of the undersigned for any failure to comply
with such requirements, or (iii) any obligation or liability of the
undersigned for profit disgorgement under Section 16(b) of the Exchange Act;
and

(4)this Power of Attorney does not relieve the undersigned from
responsibility for compliance with the undersigned's obligations under the
Exchange Act, including without limitation the reporting requirements under
Section 16 of the Exchange Act.

The undersigned hereby gives and grants the foregoing attorney-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or
could do if present, hereby ratifying all that such attorney-in-fact of, for
and on behalf of the undersigned, will lawfully do or cause to be done by
virtue of this Power of Attorney.

This Power of Attorney will remain in full force and effect until revoked by
the undersigned in a signed writing delivered to such attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date set forth below.


/s/ Steven M. Sterin        
Signature

Name: Steven M. Sterin
Dated: January 4, 2008

Witness:


/s/ Alexander M Ludlow        
Signature

Name: Alexander M Ludlow
Dated: January 4, 2008